​

​

🧠 Google Launches MedGemma for Healthcare App Developers

🔬 Breakthrough/Innovation Summary:​
Google has introduced MedGemma, a suite of open-source AI models designed to assist developers in building healthcare applications. Built on the Gemma 3 architecture, MedGemma includes a 4B multimodal model and a 27B text-only model, both optimized for medical text and image comprehension.

💡 Clinical/Business Impact:​
By offering fine-tunable and accessible models, MedGemma empowers developers to build AI tools for applications in radiology, diagnostics, and medical documentation, accelerating the growth of intelligent healthcare apps.

📊 Relevant Data & Numbers:

• Model Variants: 4B multimodal and 27B text-only.
• Use Cases: Medical image classification, clinical reasoning, and documentation support.

​🔗 Read Full Article​

💰 Cohere Health Secures $90M Series C to Expand AI Use Cases

🔬 Breakthrough/Innovation Summary:​
Cohere Health has raised $90 million in a Series C round to enhance its AI infrastructure and expand applications beyond prior authorization. The company currently automates 85% of prior auth decisions in real time, processing over 12 million requests annually.

💡 Clinical/Business Impact:​
This funding enables Cohere to scale its AI-driven tools to broader care management, reduce administrative overhead for payers and providers, and improve the speed and quality of clinical decisions.

📊 Relevant Data & Numbers:

• Annual Volume: 12 million prior auth requests.
• Automation Rate: 85% handled in real time via AI.

​🔗 Read Full Article​

💜 AI Detects Ischemic Heart Disease with Less Contrast Agent

🔬 Breakthrough/Innovation Summary:​
At ISMRM 2025, researchers revealed an AI framework capable of identifying myocardial ischemia on MRI scans using up to 88% less gadolinium-based contrast agent (GBCA). The model delivered high diagnostic performance, even at ultra-low contrast doses.

💡 Clinical/Business Impact:​
Lowering GBCA usage enhances patient safety and reduces imaging costs, while enabling repeated scanning for at-risk patients. The AI model may help standardize ischemia diagnosis and broaden access to cardiac MRI.

📊 Relevant Data & Numbers:

• Contrast Reduction: Up to 88% less GBCA used.
• Model Accuracy: r² = 0.93 vs. 0.68 with conventional methods.

​🔗 Read Full Article​

🔬 Persist AI Raises $12M and Launches Drug Formulation Cloud Lab

🔬 Breakthrough/Innovation Summary:​
Persist AI has closed a $12 million Series A to launch its Cloud Lab platform. This AI-driven system automates formulation experiments in pharmaceutical R&D using robotics and small sample volumes, enabling remote iteration of drug delivery options.

💡 Clinical/Business Impact:​
Persist AI aims to shrink drug formulation timelines from years to months. This could significantly reduce R&D costs and enable faster access to optimized therapies, especially for startups or niche pipelines.

📊 Relevant Data & Numbers:

• Funding: $12M raised in Series A.
• Throughput: 700 formulations in 2 months.

​🔗 Read Full Article​

​